Clinical study of changes in plasma endothelin and tumor necrosis factor levels in patients with coronary heart disease
Wei Liang
Abstract
Wei Liang
Abstract
AIM:To study the clinical significance of changes in plasma endothelin(ET) and tumor necrosis factor(TNF) levels in patients with coronary heart disease(CHD). METHODS:Tests of ET and TNF in blood plasma were performed in 67 patients with CHD. 28 healthy subjects served as mormal controls. RESULTS:plasma ET and TNF levels in the patients were much higher than those in the normal subjects(all P 0.01). Plasma ET and TNF increased with the progressive severity of CHD. CONCLUSION:ET and TNF are associated with CHD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the clinical significance of changes in plasma endothelin(ET) and tumor necrosis factor(TNF) levels in patients with coronary heart disease(CHD). METHODS:Tests of ET and TNF in blood plasma were performed in 67 patients with CHD. 28 healthy subjects served as mormal controls. RESULTS:plasma ET and TNF levels in the patients were much higher than those in the normal subjects(all P 0.01). Plasma ET and TNF increased with the progressive severity of CHD. CONCLUSION:ET and TNF are associated with CHD.
Key concepts: Medicine, Tumor necrosis factor alpha, Tumor necrosis factor α, Internal medicine, Coronary heart disease, Plasma levels, Endothelin receptor, Endothelin 1